Free Word download • Edit online • Save & share with Drive • Export to PDF
A Confidential Information Exchange Agreement is a binding mutual contract under which two parties each commit to protecting sensitive proprietary information they receive from the other. Where a standard one-way NDA imposes obligations only on the receiving party, a confidential information exchange agreement creates reciprocal duties — each party is simultaneously a disclosing party entitled to protection and a receiving party bound by strict non-disclosure and limited-use obligations. The agreement defines what qualifies as confidential information, restricts use to a specific permitted purpose, specifies who within each organization may access the information, and establishes what happens to the materials when the evaluation ends.
Without a mutual confidentiality agreement in place, every document, data room, product demo, or pricing conversation you share during a business evaluation is legally unprotected. A handshake understanding creates no enforceable obligations, and an after-the-fact NDA signed weeks into discussions leaves your earliest and often most sensitive disclosures entirely exposed. The consequences are concrete: a prospective partner who walks away from a deal can take your pricing strategy, technical architecture, or customer data to a competitor with no legal recourse available to you. Conversely, proceeding without protection for the other party's information exposes your organization to liability for any inadvertent misuse by your own team. A signed Confidential Information Exchange Agreement, executed before the first disclosure, gives both parties an enforceable basis for injunctive relief — the only remedy fast enough to matter when confidential information is at risk of further dissemination. This template provides the complete structure needed for most standard business evaluations, saving you from building from scratch while ensuring none of the clauses that matter most are accidentally omitted.
| If your situation is… | Use this template |
|---|---|
| Only one party is disclosing sensitive information to the other | Non-Disclosure Agreement (One-Way NDA) |
| Sharing confidential information specifically in the context of a formal M&A transaction | Mergers and Acquisitions NDA |
| Protecting confidential information shared with a new employee | Employee Confidentiality Agreement |
| Engaging a contractor who will access proprietary business information | Independent Contractor NDA |
| Sharing trade secrets and IP as part of a technology licensing deal | Technology License Agreement |
| Early-stage co-founders defining IP ownership and confidentiality between themselves | Co-Founders Agreement |
| Sharing confidential information only for the purpose of evaluating a specific business opportunity | Letter of Intent with Confidentiality Provisions |
Why it matters: Information shared before the agreement's effective date is typically not covered by its confidentiality obligations, leaving your most sensitive early-stage disclosures fully exposed.
Fix: Sign the agreement before the first meeting, call, or document exchange. If pre-execution disclosures occurred, add a retroactive effective date clause explicitly covering prior disclosures made in connection with the same purpose.
Why it matters: A one-directional NDA only protects the disclosing party's information. The other party's proprietary data — pricing, technology, customer lists — flows unprotected throughout the evaluation.
Fix: Use a mutual confidential information exchange agreement from the outset whenever both sides will be sharing sensitive materials, regardless of which party initiates the disclosure.
Why it matters: Oral disclosures in meetings, demos, and calls — where marking is impractical — fall outside the agreement's protection, creating large gaps that are only discovered after a breach.
Fix: Use a catch-all definition covering information that a reasonable person would understand to be confidential given its nature, supplemented by a procedure for oral disclosures (e.g., confirmation in writing within 5 business days).
Why it matters: If the agreement runs for 2 years and confidentiality obligations also survive for only 2 years from the effective date, information disclosed in Month 23 is protected for less than 30 days after the agreement ends.
Fix: Set the survival period as a fixed duration measured from the date of each disclosure, or from the expiration of the term — whichever gives greater protection for late-disclosed materials.
Why it matters: Without an explicit disclaimer, courts in some jurisdictions have found implied licenses to use intermingled technology when both parties contributed technical information to a joint evaluation.
Fix: Include a clear clause stating the agreement grants no rights in either party's IP and creates no obligation to disclose any specific information or to proceed to any further agreement.
Why it matters: The return-or-destruction obligation becomes technically impossible to fulfill for data stored in cloud backup systems, putting the receiving party in immediate breach of the agreement upon termination.
Fix: Add a standard carve-out stating that backups retained in routine automated systems are subject to the confidentiality obligations but need not be actively located and deleted, and will be overwritten in the ordinary course of the backup cycle.
In plain language: States why the parties are entering the agreement and defines the specific business purpose for which confidential information may be used.
The parties intend to [DESCRIBE PURPOSE, e.g., evaluate a potential joint venture relating to [DESCRIPTION]] (the 'Permitted Purpose'). Each party may receive Confidential Information from the other solely in furtherance of the Permitted Purpose.
Common mistake: Defining the permitted purpose too broadly as 'exploring a business relationship.' A vague purpose makes it nearly impossible to argue that a party exceeded their authorized use of the information.
In plain language: Specifies exactly what information is covered — whether by category, marking requirement, or a catch-all — and how each party designates its disclosures as confidential.
'Confidential Information' means any information disclosed by one party to the other, whether orally or in writing, that is designated as 'Confidential' at the time of disclosure or that reasonably should be understood to be confidential given the nature of the information and circumstances of disclosure.
Common mistake: Requiring all confidential information to be marked in writing at the time of disclosure. Oral disclosures without a follow-up written confirmation fall outside the definition, leaving significant exposures uncovered.
In plain language: Binds each party — in its role as a receiving party — not to disclose the other's confidential information to third parties or use it for any purpose beyond the permitted purpose.
Each party agrees to: (a) hold the other party's Confidential Information in strict confidence using at least the same degree of care it uses to protect its own confidential information, but no less than reasonable care; (b) not disclose Confidential Information to any third party without prior written consent; and (c) use Confidential Information solely for the Permitted Purpose.
Common mistake: Using 'reasonable efforts' as the standard of care without anchoring it to a minimum. Courts interpret 'reasonable efforts' inconsistently — adding 'but no less than reasonable care' sets a floor.
In plain language: Permits each party to share the other's confidential information internally with employees, officers, and advisors who need it for the permitted purpose, provided those individuals are bound by equivalent confidentiality obligations.
Each party may disclose the other party's Confidential Information to its employees, directors, attorneys, and financial advisors ('Representatives') who have a need to know such information for the Permitted Purpose and who are bound by confidentiality obligations at least as protective as those in this Agreement.
Common mistake: Allowing disclosure to 'affiliates' without requiring those affiliates to be contractually bound. A subsidiary that receives confidential information with no binding obligation can freely disclose it.
In plain language: Lists the standard categories of information that are not subject to confidentiality obligations because they were already known, independently developed, or publicly available.
Obligations under this Agreement do not apply to information that: (a) is or becomes publicly available through no fault of the Receiving Party; (b) was rightfully known to the Receiving Party prior to disclosure; (c) is independently developed by the Receiving Party without use of Confidential Information; or (d) is received from a third party without restriction on disclosure.
Common mistake: Failing to require the receiving party to document and prove independent development at the time it occurs. Without contemporaneous records, this exclusion is very difficult to establish in litigation.
In plain language: Addresses the scenario where a receiving party is legally ordered to disclose confidential information, requiring advance notice to the disclosing party so it can seek a protective order.
If a Receiving Party is required by law, regulation, or court order to disclose Confidential Information, it shall: (a) provide the Disclosing Party with prompt written notice before disclosure, to the extent permitted by law; (b) cooperate with the Disclosing Party's efforts to obtain a protective order or other relief; and (c) disclose only the minimum information legally required.
Common mistake: Omitting the compelled-disclosure clause entirely. Without it, a party served with a subpoena has no contractual obligation to notify the other side, potentially waiving that party's only chance to seek a protective order.
In plain language: Defines how long the agreement remains in force for new disclosures and specifies that confidentiality obligations for information disclosed during the term survive for a defined period after expiration.
This Agreement shall remain in effect for [TWO (2)] years from the Effective Date. The confidentiality obligations set forth herein shall survive expiration or termination for a period of [THREE (3)] years with respect to Confidential Information disclosed during the Term.
Common mistake: Setting the survival period equal to the agreement term, resulting in obligations that expire simultaneously with the agreement itself. Survival should extend beyond the term to cover information shared in the final months of the relationship.
In plain language: Obligates each party to return or certify destruction of the other's confidential information upon termination or request, with an exception for information retained in automated backup systems.
Upon request or termination of this Agreement, each Receiving Party shall promptly return or destroy all Confidential Information of the Disclosing Party in its possession, including all copies and derivatives thereof, and certify in writing that it has done so. Each party may retain one archival copy solely for legal compliance purposes.
Common mistake: No carve-out for automated backup systems. IT backup cycles mean destruction is often technically impractical on demand — without a carve-out, the party is immediately in breach of the return obligation.
In plain language: Acknowledges that monetary damages may be insufficient for a breach and gives the non-breaching party the right to seek injunctive relief in court without posting a bond.
Each party acknowledges that a breach of this Agreement may cause irreparable harm for which monetary damages would be an inadequate remedy. Accordingly, the non-breaching party shall be entitled to seek injunctive or other equitable relief in any court of competent jurisdiction without the requirement to post a bond.
Common mistake: Omitting the 'without posting a bond' language. Several jurisdictions require security bonds for injunctive relief — without this waiver the disclosing party may face a significant financial hurdle before a court will issue an order.
In plain language: Clarifies that the agreement does not grant either party any rights to the other's IP and does not obligate either party to actually disclose any information or enter into any further agreement.
Nothing in this Agreement grants either party any right, title, or license in or to the other party's Confidential Information or intellectual property. Neither party is obligated to disclose any particular information or to enter into any further agreement by virtue of this Agreement.
Common mistake: Omitting this clause in a mutual agreement. Without it, a court could infer an implied license to use disclosed technology — particularly when both parties' information is deeply intermingled during a co-development evaluation.
Enter the registered legal name, entity type (e.g., LLC, Inc., Ltd.), state or country of formation, and principal address for each party. Avoid using trade names or abbreviations.
💡 Confirm entity names against official corporate registry filings before signing — a mismatch between the contract name and the registered entity can complicate enforcement.
Write a one-to-three sentence description of the specific business opportunity or project the parties are evaluating together. Name the transaction type — joint venture, technology integration, M&A evaluation, co-development — rather than using a generic phrase.
💡 The narrower and more specific the permitted purpose, the easier it is to prove a party exceeded authorized use if a dispute arises.
Decide whether information must be marked to qualify or whether a catch-all covers oral and written disclosures. Include specific categories relevant to your industry — source code, financial models, customer data, clinical data — as illustrative examples in the definition.
💡 A catch-all with illustrative categories gives you maximum coverage while reducing the administrative burden of marking every document at the time of disclosure.
Set the standard of care at 'no less than reasonable care' and list the categories of Representatives who may receive the information — employees, outside counsel, financial advisors — and confirm they must be individually bound.
💡 If you anticipate involving offshore affiliates or outsourced service providers, add them explicitly to the permitted recipients list and require them to sign back-to-back obligations.
Choose an agreement term appropriate to the transaction timeline — typically 1–3 years. Set the survival period for confidentiality obligations at least 1–2 years beyond the agreement term for trade secrets, or indefinitely where applicable law permits.
💡 For information that qualifies as a trade secret under applicable law, consider adding a clause stating that trade secret obligations survive indefinitely regardless of the stated survival period.
Specify whether the default is return or destruction, the timeframe for compliance (typically 10–30 days after request or termination), the form of written certification required, and the carve-out for automated backup systems.
💡 Name a specific individual at each party who is responsible for certifying destruction — this avoids ambiguity about who must sign the certification.
Choose the jurisdiction whose law will govern the agreement and the forum — court or arbitration — for resolving disputes. Select a jurisdiction that has meaningful connection to at least one party's principal place of business.
💡 If the parties are in different countries, specify the governing law and arbitration seat explicitly — relying on a default conflicts-of-laws analysis in international disputes is expensive and unpredictable.
Both authorized signatories must sign the agreement before the first disclosure of confidential information. Pre-signature disclosures are generally not covered by the agreement's protections.
💡 Use a dated execution page with each signatory's name, title, and authority to bind the entity — a signature from someone without actual authority can void the contract.
A Confidential Information Exchange Agreement is a mutual, binding contract under which two parties each agree to protect sensitive information they receive from the other. Unlike a standard one-way NDA, both parties are simultaneously disclosors and recipients, so the confidentiality obligations run in both directions. It is the standard instrument used when two businesses explore a partnership, joint venture, M&A transaction, or co-development arrangement and must share proprietary data on both sides before any deal is signed.
The terms are closely related. An NDA (Non-Disclosure Agreement) is a broad category that includes both one-way and mutual confidentiality agreements. A Confidential Information Exchange Agreement is specifically a mutual NDA — it creates reciprocal obligations so that each party is protected when disclosing and bound when receiving. If you see the phrase 'confidential information exchange agreement,' it almost always signals a two-way structure. A standard NDA may be one-way unless explicitly stated otherwise.
Use a mutual agreement any time both parties will share sensitive information, even if the volume or sensitivity is asymmetric. Common triggers include M&A due diligence where both the buyer and target share financials and operational data, technology integration partnerships where both sides share API specs and architecture, and co-development arrangements where each party contributes proprietary IP. Using a one-way NDA when disclosures flow in both directions leaves one party's information completely unprotected.
Agreement terms of one to three years are standard for most business evaluations. The survival period for confidentiality obligations should extend beyond the term — typically one to three additional years after expiration, measured from the date of disclosure. For trade secrets, many agreements specify that obligations survive indefinitely or for the full period the information qualifies as a trade secret under applicable law. The right term depends on the sensitivity of the information and the expected length of the business relationship being evaluated.
No. A properly drafted agreement includes an explicit clause stating that it grants no license, right, or interest in either party's intellectual property. Access to confidential information is limited strictly to the permitted purpose stated in the agreement. Any broader use — incorporating the other party's technology into your own product, for example — would require a separate license agreement and would constitute a breach of the confidentiality agreement.
Standard exclusions cover four categories: information that is already in the public domain through no fault of the receiving party; information the receiving party already knew before disclosure; information independently developed by the receiving party without using the disclosed information; and information received from a third party without any confidentiality restriction. The receiving party typically bears the burden of proving an exclusion applies, which requires contemporaneous documentation of independent development or prior knowledge.
A compelled-disclosure clause requires the receiving party to give the disclosing party prompt written notice before complying with a subpoena, court order, or government demand, to the extent permitted by law. This gives the disclosing party the opportunity to seek a protective order or other relief before disclosure occurs. The receiving party must disclose only the minimum information required and must cooperate with the disclosing party's efforts to limit the disclosure.
In most jurisdictions, a contract requires offer, acceptance, and consideration to be enforceable. An unsigned agreement typically lacks clear evidence of acceptance. While some courts have enforced confidentiality obligations based on conduct — receiving and using confidential information after being put on notice — relying on implied acceptance creates significant litigation risk. Always obtain signatures from authorized representatives of both parties before any disclosures are made.
The template provides a solid structural foundation for international use, but the governing law clause, survival period, and non-disclosure obligations must be reviewed against the laws of each party's jurisdiction. Trade secret protections, compelled-disclosure obligations, and injunctive relief procedures vary significantly between the US, Canada, the UK, and EU member states. For cross-border arrangements involving parties in different legal systems, a legal review by counsel familiar with both jurisdictions is strongly recommended before execution.
The primary remedy is injunctive relief — a court order stopping the unauthorized disclosure or use of confidential information. Because monetary damages for a confidentiality breach are often difficult to quantify and inherently inadequate once disclosure has occurred, the agreement includes an acknowledgment that injunctive relief is appropriate without the need to prove actual damages or post a security bond. Monetary damages, including consequential losses and disgorgement of profits from unauthorized use, may also be available depending on jurisdiction and the specific facts of the breach.
A standard one-way NDA protects only the disclosing party's information — the receiving party takes on all the obligations while the disclosing party has none as a recipient. A Confidential Information Exchange Agreement creates reciprocal obligations so both parties are protected when disclosing and bound when receiving. Use the one-way NDA when only one side will share sensitive information; use the mutual agreement whenever both sides will disclose.
An employee confidentiality agreement runs between an employer and an individual employee, typically covering information the employee learns during the course of their employment. A Confidential Information Exchange Agreement runs between two independent business entities engaging in a specific mutual evaluation or transaction. The power dynamic, scope of information, and enforcement mechanisms differ significantly between the two.
A letter of intent outlines the proposed terms of a deal — price, structure, and key conditions — and is typically used after parties have already decided to move forward. A Confidential Information Exchange Agreement governs the information-sharing phase that comes before a letter of intent is signed. The two documents are often executed in sequence: the confidentiality agreement first, then the LOI once the parties are confident enough to commit to deal terms.
A co-founders agreement governs the long-term relationship between business partners — equity, roles, decision-making, and IP ownership. A Confidential Information Exchange Agreement is a narrower, time-limited instrument covering the pre-commitment phase when two potential partners are still evaluating whether to proceed together. A co-founders agreement is appropriate after the decision to partner is made; the confidentiality agreement protects both parties while that decision is still being evaluated.
Source code, API documentation, product roadmaps, and proprietary algorithms exchanged during integration partnerships or acquisition discussions require bilateral protection from day one.
Proprietary pricing models, client portfolio data, and trading strategies shared during fintech partnership evaluations carry regulatory confidentiality obligations that the agreement must complement.
Clinical trial data, drug formulation details, and patient datasets exchanged in co-development or licensing negotiations require confidentiality terms that interact with HIPAA and FDA regulatory frameworks.
Bills of materials, production process specifications, and supplier pricing exchanged during joint venture or supply chain integration discussions represent trade secrets that need reciprocal protection across both parties.
Trade secret protection at the federal level is governed by the Defend Trade Secrets Act (DTSA) of 2016, with additional state-level protections under most states' adoption of the Uniform Trade Secrets Act. California courts scrutinize confidentiality agreements that effectively function as non-compete restrictions. In several states, injunctive relief for a confidentiality breach requires demonstrating likelihood of success on the merits and irreparable harm — the explicit acknowledgment clause in the agreement helps satisfy this standard.
Trade secrets are protected under common law rather than a single federal statute, with courts applying equitable principles of breach of confidence. Quebec's civil law system provides a parallel framework under the Civil Code. Federal privacy legislation (PIPEDA, and its proposed successor Bill C-27) may impose additional obligations when personal data forms part of the confidential information exchanged. Non-disclosure obligations are generally enforced by Canadian courts provided the information has genuine commercial value and is not already in the public domain.
The UK relies on the equitable doctrine of breach of confidence rather than a dedicated trade secrets statute, though the Trade Secrets (Enforcement, etc.) Regulations 2018 introduced EU-aligned protections post-Brexit. Courts require the information to have the necessary quality of confidence, have been imparted in circumstances importing an obligation of confidence, and have been used without authorization. UK courts will grant interim injunctions to prevent imminent breach, but applicants must give a cross-undertaking in damages.
The EU Trade Secrets Directive (2016/943), implemented across all member states, harmonizes the definition of trade secrets and provides civil remedies for misappropriation. GDPR adds a parallel layer of obligation when personal data is included in the confidential information exchanged — data processing agreements or addenda may be required in addition to the confidentiality agreement. Injunctive relief and damages are available across the EU, but procedural requirements and the definition of 'reasonable steps' to maintain secrecy vary by member state.
| Path | Best for | Cost | Time |
|---|---|---|---|
| Use the template | Standard mutual confidentiality for domestic business evaluations between parties of comparable sophistication | Free | 15–30 minutes |
| Template + legal review | Cross-border arrangements, transactions involving trade secrets or regulated data, or situations where one party has significantly greater bargaining power | $300–$800 | 1–3 days |
| Custom drafted | M&A transactions, complex multi-party joint ventures, international co-development with IP contributions, or heavily regulated industries such as healthcare and financial services | $1,500–$5,000+ | 1–2 weeks |
This document is one of 3,000+ business & legal templates included in Business in a Box.
Access over 3,000+ business and legal templates for any business task, project or initiative.
Customize your ready-made business document template and save it in the cloud.
Share your files and folders with your team. Create a space of seamless collaboration.
"Fantastic value! I'm not sure how I'd do without it. It's worth its weight in gold and paid back for itself many times."
"I have been using Business in a Box for years. It has been the most useful source of templates I have encountered. I recommend it to anyone."
"It has been a life saver so many times I have lost count. Business in a Box has saved me so much time and as you know, time is money."
Stop downloading documents. Start operating with clarity. Business in a Box gives you the Business Operating System used by over 250,000 companies worldwide to structure, run, and grow their business.
Start free · No credit card required
